Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 4 | Alzheimer's Research & Therapy

Fig. 4

From: Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology

Fig. 4

The ratio of angiotensin II (Ang II) to angiotensin (1–7) (Ang (1-7)) (a proxy measure of ACE-2 activity) is increased, indicating reduced conversion of Ang II to Ang (1–7) in Alzheimer’s disease (AD). Bar charts showing a elevated Ang II levels in AD and b unchanged Ang (1–7) levels in AD compared with age-matched controls in mid-fontal cortex. c Bar chart showing the Ang II/Ang (1–7) ratio was significantly increased in AD (P < 0.001). The bars indicate the mean value and SEM. ***P < 0.001, ****P < 0.0001

Back to article page